HVO vs. PRTC, OXB, HZD, FARN, VRP, ARIX, AVCT, 4BB, BVXP, and CIR
Should you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include PureTech Health (PRTC), Oxford Biomedica (OXB), Horizon Discovery Group plc (HZD.L) (HZD), Faron Pharmaceuticals Oy (FARN), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Avacta Group (AVCT), 4basebio (4BB), Bioventix (BVXP), and Circassia Group (CIR). These companies are all part of the "biotechnology" industry.
hVIVO vs.
hVIVO (LON:HVO) and PureTech Health (LON:PRTC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, community ranking, media sentiment, analyst recommendations, profitability and dividends.
PureTech Health has a consensus target price of GBX 455, suggesting a potential upside of 252.17%. Given PureTech Health's stronger consensus rating and higher possible upside, analysts plainly believe PureTech Health is more favorable than hVIVO.
hVIVO has higher revenue and earnings than PureTech Health. PureTech Health is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks.
34.9% of hVIVO shares are owned by institutional investors. Comparatively, 79.9% of PureTech Health shares are owned by institutional investors. 14.0% of hVIVO shares are owned by company insiders. Comparatively, 15.9% of PureTech Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
hVIVO has a net margin of 25.96% compared to PureTech Health's net margin of -17,620.94%. hVIVO's return on equity of 47.93% beat PureTech Health's return on equity.
hVIVO has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.
PureTech Health received 407 more outperform votes than hVIVO when rated by MarketBeat users. Likewise, 86.60% of users gave PureTech Health an outperform vote while only 69.89% of users gave hVIVO an outperform vote.
In the previous week, hVIVO's average media sentiment score of 0.00 equaled PureTech Health'saverage media sentiment score.
Summary
PureTech Health beats hVIVO on 9 of the 16 factors compared between the two stocks.
Get hVIVO News Delivered to You Automatically
Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:HVO) was last updated on 3/21/2025 by MarketBeat.com Staff
